Conference Reports for NATAP EASL - European Association for the Study of the Liver Barcelona, Spain May 27-30, 2026 Back Efficacy and safety of semaglutide 2.4 mg in the Japanese subgroup of the ESSENCE study EASL 2026 May 26-30 Barcelona Atsushi Nakajima1,2, Takeshi Okanoue3, Yoichi Hiasa4, Hirokazu Takahashi5, Adel Belloum6*, Nobuyoshi Kosaka7, Tomoyuki Nishida7, Arun J
This synthetic copy of GLP-1, a hormone naturally produced by our body, plays a key role in managing blood sugar and hunger, making it a game changer for people with type 2 diabetes and obesity, giving them a fresh start by helping control their blood sugar and lose a lot of weight
Therefore, canagliflozin may potentially exert direct effects on CNS SGLT-2
A 10 mg vial covers 20 weeks at 0.5 mg, 10 weeks at 1 mg, 5 weeks at 2 mg, and about 2.5 weeks at 4 mg weekly
Our licensed providers will evaluate your needs and recommend the best medicationwhether its Wegovy, Zepbound, or another GLP-1 optionbased on your individual health profile and weight loss goals.your weight loss journey
After PS matching, the difference in treatment effects between patients who received semaglutide and those who received dulaglutide on all-cause death in each subgroup was analyzed, and the crude HR was calculated with the corresponding 95% CIs
